Speakers Adam Freund Chief Executive Officer Arda Therapeutics Angela Ibler Senior Research Scientist Novo Nordisk Elma Kurtagic Associate Director Johnson & Johnson Farhad Parhami President & CEO MAX BioPharma Henry Hsu Chief Executive Officer Allysta Katherine McCauley Associate Director & Head of Fibrosis Research Novartis Lee Borthwick Director & Chief Operating Officer Fibrofind Marc Wandsworth Principal Scientist Pfizer Massimo Attanasio Clinical Development for Immunology, Cardiovascular & Fibrosis Bristol Myers Squibb Matthew Lech Principal Research Scientist Pfizer Megan Webster Principal Scientist Newcells Biotech Min Lu Executive Director & Head of Fibrosis Morphic Therapeutics Morten Karsdal Chief Executive Officer Nordic Biosciences Natalia Reszka- Blanco Associate Director of Immuno-Oncology Morphic Therapeutics Paolo Michieli Chief Scientific Officer AgomAb Qin Ruan Principal Scientist Regeneron Pharmacueticals Richard Chen Director of Biology Discovery Merck Richard Torstenson Senior Regulatory Affairs Director AstraZeneca Robert Lafyatis Professor of Immunology University of Pittsburgh Saurabh Gupta Senior Director of Translational Medicine Bristol Myers Squibb Speaker TBC Nordic Bioscience Expertise Partner Speaker TBC FibroFind Expertise Partner Thomas Baumert Professor of Medicine and Chair & Institute Head Inserm & University of Strasbourg Tu Mai Principal Scientist Genentech Vipin Kumar Chief Scientific Officer and Professor of Medicine University of California San Diego Yunhao Tan Principal Research Scientist Abbvie Yury Popov Associate Professor of Medicine Harvard Medical School